EUVIMEDEUVIMED entdecken
Crossref

Association of Industry Payments and Botulinum Toxin Brand Use Among Physiatrists Treating Spasticity

Daniel Pierce, Creighton Harrington, Anna Woods, Sonia Schneider

PM&R · 2026-11 · 18 (S3)

DOI: 10.1002/pmrj.7_70259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PM&R, online erschienen am 10.11.2026. Verfasst von Daniel Pierce und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

No financial relationships to disclose Background and/or Objectives: Adverse Childhood Experiences (ACEs) are associated with chronic pain, psychological distress, and poorer health outcomes.However, the impact of ACE burden on outcomes following multidisciplinary pain rehabilitation remains unclear.This study evaluated whether ACE scores are associated with baseline symptom severity and treatment outcomes among patients participating in a comprehensive pain rehabilitation program.

Design

Retrospective cohort study evaluating the association between ACE and treatment outcomes among patients undergoing multidisciplinary pain rehabilitation.

Setting

Multidisciplinary Pain Rehabilitation Center (PRC) at a tertiary academic medical center.

Participants

A total of 985 adult patients with chronic pain who completed the PRC program.

Interventions

Comprehensive multidisciplinary pain rehabilitation program incorporating physical rehabilitation, behavioral therapy, pain education, and medication optimization.Main Outcome Measures: Changes from admission to discharge in depression (CES-D), pain catastrophizing (PCS), and health-related quality of life (SF-36 domains).Clinically meaningful improvement was defined using established minimally clinically important differences (MCIDs): ≥9 points for CES-D, ≥3.2 points for PCS, and ≥5 points for SF-36 domains.

Results

Patients with high ACE scores had worse baseline depression, pain catastrophizing, and several SF-36 domains compared with the low ACE group (P

Zitieren

APA

Pierce, D., Harrington, C., Woods, A., & Schneider, S. (2026). Association of Industry Payments and Botulinum Toxin Brand Use Among Physiatrists Treating Spasticity. PM&R, 18(S3). https://doi.org/10.1002/pmrj.7_70259

Vancouver

Pierce D, Harrington C, Woods A, Schneider S. Association of Industry Payments and Botulinum Toxin Brand Use Among Physiatrists Treating Spasticity. PM&R. 2026;18(S3). doi:10.1002/pmrj.7_70259

BibTeX
@article{Pierce2026,
  author = {Pierce, Daniel and Harrington, Creighton and Woods, Anna and Schneider, Sonia},
  title = {Association of Industry Payments and Botulinum Toxin Brand Use Among Physiatrists Treating Spasticity},
  journal = {PM&R},
  year = {2026},
  volume = {18},
  number = {S3},
  doi = {10.1002/pmrj.7_70259}
}
Kostenlos starten →